Myocardial Perfusion

Room 201 A/B
10:30 – 12:30

Chairs: Norbert Wilke and Gary Caputo

10:30 300. Simultaneous Detection of Myocardial Perfusion and Function by Contrast Agent Enhanced Perfusion MRI, T. Simor, G. Hild, N. Saab, M. Doyle, R.J. van der Geest, G.M. Pohost and G.A. Elgavish, University of Alabama at Birmingham, and Elgavish Paramagnetics Inc., Birmingham, AL, USA and Leiden University Medical Centre, Leiden, The Netherlands.
10:42 301. Evidence that Accumulation of GdDTPA-Albumin in Postischemic Myocardium is Associated with Myocardial Edema Rather than Infarction, M.F. Wendland, M. Saeed, G.K. Lund, N. Shafaghi and C.B. Higgins, University of California, San Francisco, CA, USA.
10:54 302. Quantitative Assessment of Myocardial Flow Reserve in a Porcine Model of LAD Stenosis, B.P. Poncelet, M.K. Atalay, H.L. Kantor, T.G. Reese, T.J. Brady and R.M. Weisskoff, Massachusetts General Hospital NMR Center, Charlestown, MA, USA and Cardiac Unit, Boston, MA, USA.
11:06 303. Myocardial Perfusion Quantification Using Dynamic MRI and Gd-DTPA in Patients after PTCA and Brachytherapy, J.P. Vallée, G. Rouault, D. Didier, V. Verin, P. Chatelain, F. Lazeyras, L. Bidaut and A. Righetti, Geneva University Hospital, Geneva, Switzerland.
11:18 304. Dipyridamole Stress MRI Perfusion: Clinical Evaluation using High Contrast Dose, Multislice Imaging, and a Novel Read Technique, A.E. Arai, F.H. Epstein, J. London, C.R. Weiss, N. Kansel, A. Moalemi, V. Dilsizian and R.S. Balaban, National Institutes of Health, Bethesda, MD, USA.
11:30 305. Assessment of First-Pass Myocardial Perfusion Imaging during Rest and Adenosine Stress: Comparison with Cardiac Catheterization, S.D. Wolff, R.A. Day, L. Santiago, F. Macaluso, R. Carey, D. Chalmers, G. Slavin, S.J. Gulotta and R.A. Hershman, Integrated Cardiovascular Therapeutics, Woodbury, NY, USA and GE Medical Systems, Milwaukee, WI, USA.
11:42 306. Assessment of Regional Myocardial Perfusion during Low-Dose Dobutamine Infusion –
Differences between Hypokinetic, Akinetic and Infarcted Myocardial Sectors,
K. Lauerma, P. Niemi, H.A. Hänninen, K. Virtanen, L. Toivonen, L.M. Voipio-Pulkki, J. Knuuti, T. Helle and H.J. Aronen, Helsinki University Central Hospital, Helsinki, Finland and University of Turku, Turku, Finland.
11:54 307. Optimal Characterization of Coronary Stenosis with an Intravascular Contrast Agent, D.L. Kraitchman, A.W. Heldman, B.B. Chin, C.L. Steinert and D.A. Bluemke, Johns Hopkins University, Baltimore, MD, USA.
12:06 308. BOLD-MRI in Patients with Coronary Artery Disease: Another Step to a 'One-Stop Shop' in Cardiology? C.M. Wacker, A.W. Hartlep, M. Bock, G. van Kaick, G. Ertl, W.R. Bauer and L.R. Schad, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany and Universität Mannheim/Heidelberg, Mannheim, Germany.
12:18 309. T2 Imaging Using 17O for Detection of Viability in Myocardial Infarction, W.J. Rogers, C.M. Kramer, D.A. Vido and N. Reichek, Allegheny General Hospital, Pittsburgh, PA, USA.

Return to ISMRM program